Skip to content

13F-HR filed by HealthCor Management, L.P.

HealthCor Management, L.P. filed this 13F-HR for the quarter ended 2017-03-31, filed 2017-05-15, with 36 holding rows worth $2,179,693,000.

Accession
0001343781-17-000004
Filed
2017-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2017

A holdings report, 36 entries on the cover page, a total value of $2,179,693,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,179,695,000 with VALUE read as thousands by filing date, 13F file number 028-11790. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BIOVERATIV INC09075E100COM5,000,000$272,300,000thousands by filing date
AETNA INC NEW00817Y108COM1,575,000$200,891,000thousands by filing date
CELGENE CORP151020104COM1,400,000$174,202,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW1,025,000$147,057,000thousands by filing date
EDWARDS LIFESCIENCES CORP COM28176E108Stock1,250,000$117,588,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM950,000$115,178,000thousands by filing date
Intuitive Surgical,Inc.46120E602COM150,000$114,970,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM1,025,000$112,084,000thousands by filing date
Merck & Co.,Inc.58933Y105COM1,475,000$93,722,000thousands by filing date
INC RESH HLDGS INC45329R109CL A1,700,000$77,945,000thousands by filing date
HAEMONETICS CORP MASS COM405024100Stock1,600,000$64,912,000thousands by filing date
ALIGN TECHNOLOGY INC COM016255101Stock525,000$60,223,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM1,225,000$53,043,000thousands by filing date
QIAGEN NVN72482123SHS NEW1,750,000$50,698,000thousands by filing date
PACIRA BIOSCIENCES INC COM695127100Stock1,100,000$50,160,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM1,550,000$45,880,000thousands by filing date
ZOETIS INC CL A98978V103Stock700,000$37,359,000thousands by filing date
BAXTER INTL INC071813109COM675,000$35,006,000thousands by filing date
MONSANTO CO NEW61166W101COM300,000$33,960,000thousands by filing date
HCA Healthcare Inc40412C101COM325,000$28,922,000thousands by filing date
ALERE INC01449J105COM725,000$28,804,000thousands by filing date
UnitedHealth Group Inc91324P102COM175,000$28,702,000thousands by filing date
CORINDUS VASCULAR ROBOTICS I218730109COM19,981,655$26,176,000thousands by filing date
HUMANA INC COM444859102Stock125,000$25,768,000thousands by filing date
Bristol-Myers Squibb Company110122108COM450,000$24,471,000thousands by filing date
MEDPACE HLDGS INC COM58506Q109Stock700,000$20,895,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM300,000$19,101,000thousands by filing date
DEXCOM INC COM252131107Stock225,000$19,064,000thousands by filing date
BARD C R INC067383109COM76,560$19,028,000thousands by filing date
Medtronic PlcG5960L103COM213,030$17,162,000thousands by filing date
AKORN INC009728106COM650,000$15,652,000thousands by filing date
CIGNA CORPORATION125509109COM100,720$14,754,000thousands by filing date
JUNO THERAPEUTICS INC48205A109COM525,000$11,650,000thousands by filing date
Danaher Corporation235851102COM118,180$10,108,000thousands by filing date
QUEST DIAGNOSTICS INC COM74834L100Stock78,982$7,755,000thousands by filing date
BECTON DICKINSON & CO075887109COM24,560$4,505,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001343781-17-000004this filing2017-05-15acceptance time not in the bulk data set